Late-breaking Abstract - Clinical Only (LBA) submission is solely for abstracts with late-breaking data from interventional clinical trials in humans and not for abstracts submitted “late”. The LBA deadline is not intended to be an extension of the general submission deadline. LBAs highlight novel and practice-changing in-human clinical studies and only apply to data that would have not otherwise have been presented as an abstract at the 41st Annual Meeting.
Authors of LBAs do not need to submit an application or a place-holder abstract. LBAs should be submitted during the LBA submission period, from July 15–Sept. 10 at 5 p.m. PT.
If a LBA is not accepted, it will not be published or presented at the meeting. There is no longer an option for it to be considered as a Regular/Early Career Investigator Award Abstract.
LBAs are considered for a limited allocation of oral and poster presentation slots on either Friday, Nov. 6 or Saturday, Nov. 7.